The number of cases consolidated in the N.J. Stryker MCL has grown to more than 600 as more plaintiffs come forward…. Read more
Stryker Hip Replacement Lawsuit
On July 6, 2012, Stryker announced a recall of two artificial hip implants—the Rejuvenate and the ABG II—because post-market surveillance data showed that the modular necks of those devices are prone to fretting and corrosion, which can cause the patient’s tissue around the implant to swell and become painful.
Stryker “decided to terminate global production of the devices after discovering a potential trend in post-market surveillance data.”
If you are experiencing pain, immobility, swelling or other medical problems that you believe might be caused by your hip implant, you don’t have to stand for this. The Rottenstein Law Group knows this and we want you to believe it. We are now accepting Stryker Rejuvenate and ABG II hip implant cases.
If you want to stand up to Stryker, then you’ll want a lawyer by your side.
Stryker put its profits before the well-being of the recipients of its products.
Now you need an attentive advocate to represent your interests alone—the right lawyer who will stand by you through process of demanding compensation for your injuries.
The Stryker hip replacement models that have been recalled have already been implanted in patients. The recall means that patients who have already undergone a surgical procedure to receive a Stryker Rejuvenate Modular hip implant or a Stryker ABG II hip implant should contact their surgeons.
The recalled Stryker hip implants are metal-on-metal (MoM) devices. MoM implants became popular because they were believed to be superior to earlier implant devices. These units replace the bone “ball-and-socket” found in a natural hip with parts made of metals such as cobalt and chromium.
The Stryker implants are different from other all-metal hip implants in that they allow surgeons to correct aspects of a patient’s anatomy. The Stryker devices were meant to offer a more personalized fit for each patient, as opposed to other hip replacements that are not as easily adaptable to individual needs.
Stryker announced the acquisition of another medical products company, while plaintiffs injured by Rejuvenate and ABG II hips await their day in court…. Read more
Stryker will close out 2013 by completing its acquisition of medical device manufacturer Mako Surgical Corp. The acquisition cost Stryker $1.65 billion…. Read more